These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 22534981

  • 1. Slow clinical improvement after treatment initiation in Leishmania/HIV coinfected patients.
    Souza GF, Biscione F, Greco DB, Rabello A.
    Rev Soc Bras Med Trop; 2012; 45(2):147-50. PubMed ID: 22534981
    [Abstract] [Full Text] [Related]

  • 2. Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil.
    Cota GF, de Sousa MR, de Mendonça AL, Patrocinio A, Assunção LS, de Faria SR, Rabello A.
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2816. PubMed ID: 24743472
    [Abstract] [Full Text] [Related]

  • 3. Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia.
    van Griensven J, Mengesha B, Mekonnen T, Fikre H, Takele Y, Adem E, Mohammed R, Ritmeijer K, Vogt F, Adriaensen W, Diro E.
    Front Cell Infect Microbiol; 2018 Apr; 8():94. PubMed ID: 29651411
    [Abstract] [Full Text] [Related]

  • 4. Two cases of relapsed HIV-associated visceral leishmaniasis successfully treated with combination therapy.
    Mastroianni A, Gaibani P, Rossini G, Vocale C, Re MC, Ravaglia G, Sambri V, Varani S.
    AIDS Res Ther; 2018 Dec 20; 15(1):27. PubMed ID: 30572924
    [Abstract] [Full Text] [Related]

  • 5. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
    Medrano FJ, Hernández-Quero J, Jiménez E, Pineda JA, Rivero A, Sánchez-Quijano A, Velez ID, Viciana P, Castillo R, Reyes MJ.
    AIDS; 1992 Dec 20; 6(12):1499-503. PubMed ID: 1362880
    [Abstract] [Full Text] [Related]

  • 6. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
    ter Horst R, Collin SM, Ritmeijer K, Bogale A, Davidson RN.
    Clin Infect Dis; 2008 Jun 01; 46(11):1702-9. PubMed ID: 18419422
    [Abstract] [Full Text] [Related]

  • 7. [Visceral leishmaniasis: a comparative study of patients with and without human immunodeficiency virus infection].
    Reus S, Sánchez R, Portilla J, Boix V, Priego M, Merino E, Román F.
    Enferm Infecc Microbiol Clin; 1999 Dec 01; 17(10):515-20. PubMed ID: 10650648
    [Abstract] [Full Text] [Related]

  • 8. Is Visceral Leishmaniasis the same in HIV-coinfected adults?
    Henn GAL, Ramos Júnior AN, Colares JKB, Mendes LP, Silveira JGC, Lima AAF, Aires BP, Façanha MC.
    Braz J Infect Dis; 2018 Dec 01; 22(2):92-98. PubMed ID: 29601790
    [Abstract] [Full Text] [Related]

  • 9. Antigen Detection in Urine for Noninvasive Diagnosis and Treatment Monitoring of Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients: An Exploratory Analysis from Ethiopia.
    Vogt F, Mengesha B, Asmamaw H, Mekonnen T, Fikre H, Takele Y, Adem E, Mohammed R, Ritmeijer K, Adriaensen W, Melsew Y, van Griensven J, Diro E.
    Am J Trop Med Hyg; 2018 Oct 01; 99(4):957-966. PubMed ID: 30084342
    [Abstract] [Full Text] [Related]

  • 10. The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study.
    Abongomera C, Diro E, de Lima Pereira A, Buyze J, Stille K, Ahmed F, van Griensven J, Ritmeijer K.
    PLoS Negl Trop Dis; 2018 May 01; 12(5):e0006527. PubMed ID: 29799869
    [Abstract] [Full Text] [Related]

  • 11. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.
    Lachaud L, Bourgeois N, Plourde M, Leprohon P, Bastien P, Ouellette M.
    Clin Infect Dis; 2009 Jan 15; 48(2):e16-22. PubMed ID: 19093811
    [Abstract] [Full Text] [Related]

  • 12. Asymptomatic Leishmania infection in HIV-positive outpatients on antiretroviral therapy in Pernambuco, Brazil.
    Guedes DL, Justo AM, Barbosa Júnior WL, Silva EDD, Aquino SR, Lima Junior MSDC, Montarroyos U, Bezerra GSN, Vieira AVB, Pereira VRA, Medeiros ZM.
    PLoS Negl Trop Dis; 2021 Jan 15; 15(1):e0009067. PubMed ID: 33476331
    [Abstract] [Full Text] [Related]

  • 13. Visceral leishmaniasis mimicking as second line anti retroviral therapy failure.
    Yanamandra U, Jairam A, Shankar S, Negi R, Guleria B, Nair V.
    Intern Med; 2011 Jan 15; 50(22):2855-8. PubMed ID: 22082903
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Predictors of relapse of visceral leishmaniasis in inner São Paulo State, Brazil.
    Simão JC, Victória C, Fortaleza CMCB.
    Int J Infect Dis; 2020 Jun 15; 95():44-49. PubMed ID: 32088340
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Case Report: No Response to Liposomal Daunorubicin in a Patient with Drug-Resistant HIV-Associated Visceral Leishmaniasis.
    Gow NJ, Davidson RN, Ticehurst R, Burns A, Thomas MG.
    PLoS Negl Trop Dis; 2015 Jun 15; 9(8):e0003983. PubMed ID: 26305562
    [Abstract] [Full Text] [Related]

  • 19. Does timing of antiretroviral treatment influence treatment outcomes of visceral leishmaniasis in Northwest Ethiopia?
    Aderie EM, Diro E, Zachariah R, da Fonseca MS, Abongomera C, Dolamo BL, Ritmeijer K.
    Trans R Soc Trop Med Hyg; 2017 Mar 01; 111(3):107-116. PubMed ID: 28633331
    [Abstract] [Full Text] [Related]

  • 20. Visceral leishmaniasis with HIV co-infection and cervical lymphadenopathy.
    Mishra S, Shukla A, Tripathi AK, Kumar A.
    BMJ Case Rep; 2013 Apr 09; 2013():. PubMed ID: 23576652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.